Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Top 15 countries for geographical coverage of MTRC services

20 Mar 2023

Since 2017 MTRC has provided reimbursement and HEOR services for the medical device and IVD industry in Europe. 

We specialize in Pan-European projects and worked in 34 countries in Europe. In this post, we summarized statistics about our experience with reimbursement projects in different EU countries. Three leading countries are England (273 projects), Germany (247 projects), and France (203 projects). 

The full list of the top 15 countries includes:

  • England - 273 projects
  • Germany – 247 projects
  • France – 203 projects
  • Italy – 186 projects
  • Netherlands – 143 projects
  • Sweden - 137 projects
  • Norway - 121 projects
  • Denmark – 120 projects
  • Switzerland – 110 projects
  • Belgium – 108 projects
  • Austria – 88 projects
  • Finland – 66 projects
  • Spain – 61 projects
  • Russia – 28 projects
  • Poland – 28 projects

With MTRC, you can avoid the hassle of contracting multiple vendors by working with a single professional provider of services. 

Finally, as many of our clients know, we acknowledge the budget limitations of the med tech industry. We offer a cost-effective approach with the provision of high-quality (we are ISO 9001:2015-certified, and our average NPS is 10/10) but affordable (36% of our business comes from SMEs) service to our clients.

Contact us to discuss your needs in the field of European med tech market access.